Home Tags Sanofi

Tag: Sanofi

Sanofi

Sanofi Refiles $3.2B Translate Bio Buyout With FTC

Sanofi and Translate Bio are refiling paperwork on their US$3.2 billion merger to give the agency more time to review. In a Securities and Exchange...
Sanofi

Sanofi Announces $3.2B Translate Bio Vaccine Deal

Sanofi has agreed to buy US biotech company Translate Bio in a US$3.2 billion deal, as it bets on next-generation mRNA vaccine technology beyond...
Sanofi

Sanofi, Novo Insulin Price-Fixing Suit Advances

Three major drugmakers persuaded a federal judge to drop antitrust claims in a case accusing them of overcharging for insulin while paying insurers kickbacks,...
Sanofi

Sanofi May Take Mylan To Court Again Over EpiPen Antitrust Woes

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its...
pfizer

Pfizer To Grow COVID-19 Vaccine Production With Sanofi Deal

Sanofi has agreed to produce millions of doses of BioNTech and Pfizer’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts, reported Bloomberg. The...
Sanofi

Sanofi In Deal To Buy Biotech Company for $3.4B

Sanofi agreed to acquire US biotech company Principia Biopharma for about US$3.4 billion as the French drugmaker pivots toward innovative therapies to spur growth...
law

1st Circuit Reverses Sanofi Carlsberg Dismissal

Purchasers of a diabetes drug can pursue antitrust claims based on allegations that drugmaker Sanofi-Aventis wrongfully extended its monopoly by improperly listing a patent...

1st Circuit Revives Antitrust Case Against Sanofi

A US appeals court has revived a class action lawsuit alleging Sanofi-Aventis improperly delayed generic versions of its diabetes treatment Lantus from entering the...

US: Sanofi buys Synthorx for $2.5B

Sanofi has agreed to buy cancer biotech company Synthorx for $2.5 billion, the first big move by new Chief Executive Paul Hudson to reinvigorate...

US: Sanofi seeks billions in EpiPen antitrust suit

Sanofi wants Mylan to pay up to US$11.7 billion in damages for engaging in a scheme to squelch competition to its EpiPen allergy treatment,...
Enable Notifications    OK No thanks